BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$9.09B
1-Year Return
13.74%
This Quarter Return
-1.67%
1 Year Return
+13.74%
3 Year Return
+18.18%
5 Year Return
–
10 Year Return
–
AUM
$3.57B
AUM Growth
-$477M
(-12%)
Cap. Flow
-$289M
Cap. Flow
% of AUM
-8.09%
Top 10 Holdings %
Top 10 Hldgs %
45.63%
Holding
1,500
New
522
Increased
310
Reduced
227
Closed
409
Top Buys
| 1 |
Apple
AAPL
|
+$80.5M |
| 2 |
NVIDIA
NVDA
|
+$62.7M |
| 3 |
Pfizer
PFE
|
+$56M |
| 4 |
Blackrock
BLK
|
+$41.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$35.1M |
Top Sells
| 1 |
iShares Bitcoin Trust
IBIT
|
+$190M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$187M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$149M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$94.2M |
| 5 |
Pampa Energía
PAM
|
+$22.8M |
Sector Composition
| 1 | Technology | 13.66% |
| 2 | Financials | 13.23% |
| 3 | Industrials | 6.58% |
| 4 | Healthcare | 6.28% |
| 5 | Consumer Discretionary | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Aldeyra Therapeutics
ALDX
$324M
| $65.5K | ﹤0.01% |
+11,397
| New | +$65.5K |
|
1027
KULR Technology Group
KULR
$185M
| $65.3K | ﹤0.01% |
6,274
+4,824
| +333% | +$50.2K |
|
1028
Rezolute
RZLT
$669M
| $63.4K | ﹤0.01% |
+21,846
| New | +$63.4K |
|
1029
Emergent Biosolutions
EBS
$434M
| $63.1K | ﹤0.01% |
+12,981
| New | +$63.1K |
|
|
SERV
1030
Serve Robotics
SERV
$747M
| $61.5K | ﹤0.01% |
+10,701
| New | +$61.5K |
|
|
PLG
1031
Platinum Group Metals
PLG
$205M
| $61K | ﹤0.01% |
50,000
| – | – |
|
1032
Ginkgo Bioworks
DNA
$593M
| $57.8K | ﹤0.01% |
+10,145
| New | +$57.8K |
|
1033
Prime Medicine
PRME
$726M
| $56.7K | ﹤0.01% |
+28,478
| New | +$56.7K |
|
1034
Bridger Aerospace
BAER
$105M
| $56.5K | ﹤0.01% |
+50,000
| New | +$56.5K |
|
1035
Evolution Petroleum
EPM
$179M
| $55.8K | ﹤0.01% |
+10,774
| New | +$55.8K |
|
1036
Ironwood Pharmaceuticals
IRWD
$213M
| $50.9K | ﹤0.01% |
+34,658
| New | +$50.9K |
|
1037
4D Molecular Therapeutics
FDMT
$318M
| $47.8K | ﹤0.01% |
+14,800
| New | +$47.8K |
|
1038
Esperion Therapeutics
ESPR
$573M
| $47.4K | ﹤0.01% |
+32,933
| New | +$47.4K |
|
1039
Neumora Therapeutics
NMRA
$262M
| $46.3K | ﹤0.01% |
46,254
-34,305
| -43% | -$34.3K |
|
1040
Solid Power
SLDP
$689M
| $46.1K | ﹤0.01% |
+43,913
| New | +$46.1K |
|
|
CGC
1041
Canopy Growth
CGC
$427M
| $45K | ﹤0.01% |
50,000
| – | – |
|
1042
Definitive Healthcare
DH
$432M
| $44.1K | ﹤0.01% |
+15,255
| New | +$44.1K |
|
1043
Sangamo Therapeutics
SGMO
$152M
| $43.6K | ﹤0.01% |
+66,018
| New | +$43.6K |
|
1044
CS Disco
LAW
$357M
| $43.4K | ﹤0.01% |
+10,608
| New | +$43.4K |
|
1045
United States Antimony
UAMY
$613M
| $43.4K | ﹤0.01% |
+19,715
| New | +$43.4K |
|
1046
Eledon Pharmaceuticals
ELDN
$145M
| $41K | ﹤0.01% |
+12,080
| New | +$41K |
|
1047
Amylyx Pharmaceuticals
AMLX
$1.24B
| $40.1K | ﹤0.01% |
+11,330
| New | +$40.1K |
|
|
SRG
1048
Seritage Growth Properties
SRG
$237M
| $35.6K | ﹤0.01% |
+11,028
| New | +$35.6K |
|
1049
Protalix BioTherapeutics
PLX
$144M
| $34.5K | ﹤0.01% |
+13,474
| New | +$34.5K |
|
1050
BuzzFeed, Inc. Warrant
BZFDW
$2.5M
| $33.2K | ﹤0.01% |
603,324
| – | – |
|